Gabapentinoids‐duloxetine combination therapy for chronic pain: A mechanism oriented rational to bridge theoretical knowledge and real life setting
Stefania Nobili, Maurizio Evangelista, Elena Lucarini, Elena G Giugliano, Carla Ghelardini, Laura Micheli, Lorenzo Di Cesare Mannelli · 2026
Read Gabapentinoids‐duloxetine combination therapy for chronic pain: A mechanism oriented rational to bridge theoretical knowledge and real life setting by Stefania Nobili, Maurizio Evangelista, Elena Lucarini, Elena G Giugliano, Carla Ghelardini, Laura Micheli, Lorenzo Di Cesare Mannelli (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13619089.txt.
Description
Stefania Nobili and six colleagues wrote a 2026 review on pairing two drug families for long-lasting pain. Gabapentinoids calm overactive nerve signaling, while duloxetine, an antidepressant, strengthens the brain's own pain-damping pathways. The authors argue that using both together follows logically from how chronic pain works, since such pain mixes nerve damage, tissue signals, and altered central processing.
Evidence summarized here covers diabetic nerve pain, pain after shingles, and fibromyalgia, where each drug alone already helps some patients. Pregabalin gets special note for fast dose adjustment and for easing anxiety-linked sleep problems. Early studies suggest the pairing may help people whose pain remains after one drug alone. The trials so far are small and short, so the authors frame the combination as a proof of concept needing fuller testing.
Catalog record
| CREATOR | Stefania Nobili, Maurizio Evangelista, Elena Lucarini, Elena G Giugliano, Carla Ghelardini, Laura Micheli, Lorenzo Di Cesare Mannelli |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 93721 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |